Danaher Co. (NYSE:DHR) Shares Purchased by Gordian Capital Singapore Pte Ltd

Gordian Capital Singapore Pte Ltd boosted its position in shares of Danaher Co. (NYSE:DHR) by 400.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,000 shares of the conglomerate’s stock after acquiring an additional 5,600 shares during the quarter. Danaher comprises 0.8% of Gordian Capital Singapore Pte Ltd’s holdings, making the stock its 28th biggest position. Gordian Capital Singapore Pte Ltd’s holdings in Danaher were worth $1,607,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter valued at $27,000. Golden State Wealth Management LLC acquired a new position in Danaher in the fourth quarter valued at $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher in the fourth quarter valued at about $31,000. Pineridge Advisors LLC boosted its stake in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the period. Finally, Kentucky Trust Co acquired a new stake in shares of Danaher during the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR opened at $186.50 on Thursday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a market cap of $133.47 billion, a PE ratio of 35.32, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company has a 50-day simple moving average of $196.07 and a 200-day simple moving average of $216.57. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.69%. Danaher’s dividend payout ratio (DPR) is 24.85%.

Analyst Ratings Changes

Several research firms have commented on DHR. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. The Goldman Sachs Group dropped their target price on Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. JPMorgan Chase & Co. decreased their price target on Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a report on Tuesday, April 22nd. Jefferies Financial Group dropped their price objective on shares of Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research note on Tuesday, April 22nd. Finally, Robert W. Baird reduced their target price on shares of Danaher from $231.00 to $225.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $263.24.

Insider Activity

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the firm’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.